Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma
Clinical trial NCT03071406 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03071406
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-14
- Primary completion
- 2022-04-06
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.